FDA approves pill with sensor to track patients adherence

The FDA approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.

[Read More]


The Pulse

The Pulse on Technology by Elisa Cascade

To set the stage for a column on paperless clinical trials, I’d like to relay a recent conversation with a PI in the U.K. working on a trial sponsored by a major pharmaceutical company. 

[Read More]

Clinical Intelligence

Awards & Advancement

JobWatch

Nasdaq GlobeNewswire